SCHEDULE OF STOCK OPTIONS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Equity [Abstract]
Number of Shares, Outstanding at beginning	929,765	797,373
Weighted Average Exercise Price, Outstanding at beginning	$ 1.53	$ 1.99
Weighted Average Grant Date Fair Value, Outstanding at beginning	$ 2.50	$ 0.72
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years 3 months 18 days	6 years 1 month 6 days	5 years
Number of Shares, Granted	124,100	378,800
Weighted Average Exercise Price, Granted	$ 2.98	$ 0.94
Weighted Average Grant Date Fair Value, Granted	$ 2.32	$ 5.22
Number of Shares, Expired, forfeited, or cancelled	(692,475)	(246,408)
Weighted Average Exercise Price, Expired, forfeited, or cancelled	$ 1.69	$ 1.94
Weighted Average Grant Date Fair Value, Expired, forfeited, or cancelled	$ 1.62	$ 0.88
Aggregate Intrinsic Value, Outstanding	$ 2,537,245
Number of Shares,Options assumed pursuant to acquisition of Magic Med	973,840
Weighted Average Exercise Price, Options assumed pursuant to acquisition of Magic Med	$ 1.34
Weighted Average Grant Date Fair Value, Options assumed pursuant to acquisition of Magic Med	$ 1.84
Number of Shares, Exercised	(143,796)
Weighted Average Exercise Price, Exercised	$ 0.23
Weighted Average Grant Date Fair Value, Exercised	$ 5.69
Number of Shares, Outstanding at end	1,191,434	929,765	797,373
Weighted Average Exercise Price, Outstanding at end	$ 1.58	$ 1.53	$ 1.99
Weighted Average Grant Date Fair Value, Outstanding at end	$ 2.07	$ 2.50	$ 0.72
Aggregate Intrinsic Value, Outstanding	$ 34,333	$ 2,537,245
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	958,915
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 1.50
Weighted Average Grant Date Fair Value, Exercisable	$ 2.01
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	4 years 6 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	$ 13,733